Zhongchao (NASDAQ:ZCMD) Cut to “Sell” at Wall Street Zen

Wall Street Zen downgraded shares of Zhongchao (NASDAQ:ZCMD) from a hold rating to a sell rating in a research report released on Saturday morning,Wall Street Zen reports.

Separately, Weiss Ratings raised shares of Zhongchao from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Monday, August 24th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Zhongchao currently has an average rating of “Sell”.

Zhongchao Stock Performance

Zhongchao stock opened at $0.79 on Friday. The company’s 50-day moving average is $1.13 and its 200-day moving average is $71.14. Zhongchao has a fifty-two week low of $0.71 and a fifty-two week high of $967.20.

About Zhongchao

Zhongchao Inc is a China-based healthcare services company that provides medical education and patient-management services. The company focuses on supporting healthcare professionals and patients through digital platforms, educational programs and related healthcare resources.

Its business activities have included continuing medical education for physicians and other medical professionals, as well as disease-management and patient-support services. Zhongchao has particularly emphasized oncology-related healthcare education and management, helping connect medical information, professional training and patient services.

The company primarily serves the healthcare market in China through online and offline offerings.